Challenges of Hepatitis C Virus Treatment in Thalassemia
Thalassemic patients, especially in limited resources settings, are prone to multi-transfusion acquired Hepatitis C virus (HCV). After the discovery of direct acting antivirals (DAAs), many programs were designed to achieve HCV eradication both on the macro-elimination and micro-elimination axes. Th...
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/80184 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Sea el primero en dejar un comentario!